| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |